BJ Vlieg-Boerstra

Dr. BJ Vlieg-Boerstra

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2021 in Allergy
Verified
Journal Article
Closed access
PDF file
AMAntonella Muraro
Antonella Muraro
MWMargitta Worm
Margitta Worm
CACherry Alviani
Cherry Alviani
VCVictoria Cardona
Victoria Cardona
ADAudrey DunnGalvin
Audrey DunnGalvin
EGEuropean Academy of Allergy, Clinical Immunology Food Allergy, Anaphylaxis Guidelines Group
European Academy of Allergy, Clinical Immunology Food Allergy, Anaphylaxis Guidelines Group

10 October 2023 in Allergy
Verified
Journal Article
Open access
ASAlexandra F Figueira Santos
Alexandra F Figueira Santos
CRCarmen Riggioni
Carmen Riggioni
IAIoana Agache
Ioana Agache
CACezmi A. Akdis
Cezmi A. Akdis
MAMubeccel Akdis
Mubeccel Akdis
ISIsabel Skypala
Isabel Skypala
This European Academy of Allergy and Clinical Immunology guideline provides recommendations for diagnosing IgE‐mediated food allergy and was developed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach. Food allergy diagnosis starts with an allergy‐focused clinical history followed by tests to determine IgE sensitization, such as serum allergen‐specific IgE (sIgE) and skin prick test (SPT), and the basophil activation test (BAT), if available. Evidence for IgE sensitization should be sought for any suspected foods. The diagnosis of allergy to some foods, such as peanut and cashew nut, is well supported by SPT and serum sIgE, whereas there are less data and the performance of these tests is poorer for other foods, such as wheat and soya. The measurement of sIgE to allergen components such as Ara h 2 from peanut, Cor a 14 from hazelnut and Ana o 3 from cashew can be useful to further support the diagnosis, especially in pollen‐sensitized individuals. BAT to peanut and sesame can be used additionally. The reference standard for food allergy diagnosis is the oral food challenge (OFC). OFC should be performed in equivocal cases. For practical reasons, open challenges are suitable in most cases. Reassessment of food allergic children with allergy tests and/or OFCs periodically over time will enable reintroduction of food into the diet in the case of spontaneous acquisition of oral tolerance.

7 November 2022 in Allergy
Verified
Journal Article
Open access
GSGiulia C. I. Spolidoro
Giulia C. I. Spolidoro
YAYohannes Tesfaye Amera
Yohannes Tesfaye Amera
MAMohamed Mustafa Ali
Mohamed Mustafa Ali
SNSungkutu Nyassi
Sungkutu Nyassi
DLDaniil Lisik
Daniil Lisik
BNBright I. Nwaru
Bright I. Nwaru
Food allergy (FA) is increasingly reported in Europe, however, the latest prevalence estimates were based on studies published a decade ago. The present work provides the most updated estimates of the prevalence and trends of FA in Europe. Databases were searched for studies published between 2012 and 2021, added to studies published up to 2012. In total, 110 studies were included in this update. Most studies were graded as moderate risk of bias. Pooled lifetime and point prevalence of self‐reported FA were 19.9% (95% CI 16.6–23.3) and 13.1% (95% CI 11.3–14.8), respectively. The point prevalence of sensitization based on specific IgE (slgE) was 16.6% (95% CI 12.3–20.8), skin prick test (SPT) 5.7% (95% CI 3.9–7.4), and positive food challenge 0.8% (95% CI 0.5–0.9). While lifetime prevalence of self‐reported FA and food challenge positivity only slightly changed, the point prevalence of self‐reported FA, sIgE and SPT positivity increased from previous estimates. This may reflect a real increase, increased awareness, increased number of foods assessed, or increased number of studies from countries with less data in the first review. Future studies require rigorous designs and implementation of standardized methodology in diagnosing FA, including use of double‐blinded placebo‐controlled food challenge to minimize potential biases.

30 October 2024 in Allergy
Verified
Journal Article
Open access
ASAlexandra F Figueira Santos
Alexandra F Figueira Santos
CRCarmen Riggioni
Carmen Riggioni
IAIoana Agache
Ioana Agache
CACezmi A. Akdis
Cezmi A. Akdis
MAMubeccel Akdis
Mubeccel Akdis
ISIsabel Skypala
Isabel Skypala
This European Academy of Allergy and Clinical Immunology (EAACI) guideline provides recommendations for the management of IgE‐mediated food allergy and was developed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach. Following the confirmation of IgE‐mediated food allergy diagnosis, allergen avoidance and dietary advice (with support of a specialised dietitian, if possible) together with the provision of a written treatment plan, education on the recognition of allergic symptoms and prescription of medication including adrenaline using an auto‐injector are essential. Patients with significant anxiety and requirement for coping strategies may benefit from support from a clinical psychologist. As immunomodulatory interventions, omalizumab is suggested for treatment of IgE‐mediated food allergy in children from the age of 1 and adults; and oral allergen‐specific immunotherapy is recommended for children and adolescents with peanut allergy and suggested for milk and egg allergies (generally after 4 years of age for milk and egg). Sublingual and epicutaneous immunotherapy are suggested for peanut allergy but are not yet available at the point of care. Future research into disease modifying treatments for IgE‐mediated food allergy are highly needed, with standardised and patient‐focused protocols and outcomes.

5 July 2023 in Allergy
Verified
Journal Article
Open access
GSGiulia C. I. Spolidoro
Giulia C. I. Spolidoro
MAMohamed Mustafa Ali
Mohamed Mustafa Ali
YAYohannes Tesfaye Amera
Yohannes Tesfaye Amera
SNSungkutu Nyassi
Sungkutu Nyassi
DLDaniil Lisik
Daniil Lisik
BNBright I. Nwaru
Bright I. Nwaru
In 2014, the European Academy of Allergy and Clinical Immunology published prevalence estimates for food allergy (FA) and food sensitization (FS) to the so‐called eight big food allergens (i.e. cow's milk, egg, wheat, soy, peanut, tree nuts, fish and shellfish) in Europe for studies published between 2000 and 2012. The current work provides 10‐year updated prevalence estimates for these food allergens. A protocol was registered on PROSPERO before starting the research (reference number CRD42021266657). Six databases were searched for studies published 2012–2021, added to studies published up to 2012, resulting in a total of 93 studies. Most studies were graded as at moderate risk of bias. The overall pooled estimates for all age groups of self‐reported lifetime prevalence were as follows: cow's milk (5.7%, 95% confidence interval 4.4–6.9), egg (2.4%, 1.8–3.0), wheat (1.6%, 0.9–2.3), soy (0.5%, 0.3–0.7), peanut (1.5%, 1.0–2.1), tree nuts (0.9%, 0.6–1.2), fish (1.4%, 0.8–2.0) and shellfish (0.4%, 0.3–0.6). The point prevalence of food challenge‐verified allergy were as follows: cow's milk (0.3%, 0.1–0.5), egg (0.8%, 0.5–1.2), wheat (0.1%, 0.01–0.2), soy (0.3%, 0.1–0.4), peanut (0.1%, 0.0–0.2), tree nuts (0.04%, 0.02–0.1), fish (0.02%, 0.0–0.1) and shellfish (0.1%, 0.0–0.2). With some exceptions, the prevalence of allergy to common foods did not substantially change during the last decade; variations by European regions were observed.

29 April 2019 in Allergy
Verified
Journal Article
Open access
PDF file
CVCarina Venter
Carina Venter
RMRosan W. Meyer
Rosan W. Meyer
BNBright I. Nwaru
Bright I. Nwaru
CRCaroline Roduit
Caroline Roduit
Eva UntersmayerEva Untersmayer
Eva Untersmayer
LOLiam O’Mahony
Liam O’Mahony
The prevalence of allergic diseases such as allergic rhinitis, asthma, food allergy, and atopic dermatitis has increased dramatically during the last decades, which is associated with altered environmental exposures and lifestyle practices. The purpose of this review was to highlight the potential role for dietary fatty acids, in the prevention and management of these disorders. In addition to their nutritive value, fatty acids have important immunoregulatory effects. Fatty acid‐associated biological mechanisms, human epidemiology, and intervention studies are summarized in this review. The influence of genetics and the microbiome on fatty acid metabolism is also discussed. Despite critical gaps in our current knowledge, it is increasingly apparent that dietary intake of fatty acids may influence the development of inflammatory and tolerogenic immune responses. However, the lack of standardized formats (ie, food versus supplement) and standardized doses, and frequently a lack of prestudy serum fatty acid level assessments in clinical studies significantly limit our ability to compare allergy outcomes across studies and to provide clear recommendations at this time. Future studies must address these limitations and individualized medical approaches should consider the inclusion of specific dietary factors for the prevention and management of asthma, food allergy, and atopic dermatitis.